close menu
X

Anfarm Hellas S.A. - Main Section

Anfarm Hellas S.A. - Main Component

Active Substance Strength Form
Amikacin 1g/4ml Inj.Sol
Apixaban 2.5mg/tab & 5mg/tab F.C.Tabs
Brivaracetam 10mg/ml Sol.Inf
Brivaracetam 10mg/ml Oral Solution
Ceftaroline Fosamil 600mg/vial Pd.C.So.In
Clindamycin 150mg/ml Inf.Sol
Dalbavancin 500mg/vial Pd.C.So.In
Ertapenem 1g/Vial Pd.C.So.In
Isavuconazole 200mg/vial Pd.C.So.In
Lacosamide 10mg/ml Sol.Inf
Lacosamide 10mg/ml Oral Solution
Vancomycin 1g/vial Pd.Sol.Inf
Vildagliptin/Metformin (50+850)mg/tab & (50+1000)mg/tab Tabs

Alphabetically

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Active Substance Strength Form
Amikacin 1g/4ml Inj.Sol
Apixaban 2.5mg/tab & 5mg/tab F.C.Tabs
Brivaracetam 10mg/ml Sol.Inf
Brivaracetam 10mg/ml Oral Solution
Ceftaroline Fosamil 600mg/vial Pd.C.So.In
Clindamycin 150mg/ml Inf.Sol
Dalbavancin 500mg/vial Pd.C.So.In
Ertapenem 1g/Vial Pd.C.So.In
Isavuconazole 200mg/vial Pd.C.So.In
Lacosamide 10mg/ml Sol.Inf
Lacosamide 10mg/ml Oral Solution
Vancomycin 1g/vial Pd.Sol.Inf
Vildagliptin/Metformin (50+850)mg/tab & (50+1000)mg/tab Tabs
Active Substance Strength Form Dossier Availability
Amikacin 1g/4ml Inj.Sol Q3 2021
Apixaban 2.5mg/tab & 5mg/tab F.C.Tabs on going
Brivaracetam 10mg/ml Sol.Inf Q3 2022
Brivaracetam 10mg/ml Oral Solution Q4 2022
Ceftaroline Fosamil 600mg/vial Pd.C.So.In on going
Clindamycin 150mg/ml Inf.Sol Q3 2022
Dalbavancin 500mg/vial Pd.C.So.In on going
Ertapenem 1g/Vial Pd.C.So.In on going
Isavuconazole 200mg/vial Pd.C.So.In on going
Lacosamide 10mg/ml Sol.Inf Q1 2021
Lacosamide 10mg/ml Oral Solution Q2 2022
Vancomycin 1g/vial Pd.Sol.Inf Q3 2021
Vildagliptin/Metformin (50+850)mg/tab & (50+1000)mg/tab Tabs Q3 2021